These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1490758)

  • 21. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of peritoneal equilibration testing in treatment of congenital lactic acidosis by acute peritoneal dialysis.
    Aufricht C; Arbeiter K
    Am J Perinatol; 1997 Mar; 14(3):145-6. PubMed ID: 9259916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution.
    Ing BL; Gupta DK; Nawab ZM; Zhou FQ; Rahman MA; Daugirdas JT
    Int J Artif Organs; 1988 Sep; 11(5):351-4. PubMed ID: 2847987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advantages of pyruvate over lactate in peritoneal dialysis solutions.
    Zhou FQ
    Acta Pharmacol Sin; 2001 May; 22(5):385-92. PubMed ID: 11743883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactate-containing versus bicarbonate-containing peritoneal dialysis solutions.
    Ing TS; Zhou XJ; Yu AW; Vaziru ND
    Perit Dial Int; 1992; 12(3):276-7. PubMed ID: 1511042
    [No Abstract]   [Full Text] [Related]  

  • 29. Peritoneal dialysis and inflammation.
    Velloso MS; Otoni A; de Paula Sabino A; de Castro WV; Pinto SW; Marinho MA; Rios DR
    Clin Chim Acta; 2014 Mar; 430():109-14. PubMed ID: 24333488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
    Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
    Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular glutathione in human peritoneal mesothelial cells exposed in vitro to dialysis fluid.
    Breborowicz A; Rodela H; Martis L; Oreopoulos DG
    Int J Artif Organs; 1996 May; 19(5):268-75. PubMed ID: 8791146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
    Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents.
    Schambye HT; Pedersen FB; Wang P
    Adv Perit Dial; 1992; 8():42-6. PubMed ID: 1361838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
    Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
    BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective effect of ginsenosides on human peritoneal mesothelial cell against lactate-based peritoneal dialysis solutions--induced injury in vitro].
    Ye Y; Peng YM; Liu FY
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):317-20. PubMed ID: 12536722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new peritoneal dialysis solutions: friends only, or foes in part?
    ter Wee PM; van Ittersum FJ
    Nat Clin Pract Nephrol; 2007 Nov; 3(11):604-12. PubMed ID: 17957197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new lactate-based, plasticizer-free, neutral peritoneal dialysis fluid provided in a two-compartment system: effect on peripheral leukocyte function.
    Alscher DM; Pauli-Magnus C; Kirchgessner J; Kuhlmann U; Mettang T
    Nephron; 2000 Sep; 86(1):62-9. PubMed ID: 10971155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
    Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
    Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
    Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
    Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.